Novasenta

Private

Pittsburgh, PennsylvaniaHealthcare & Life Scienceshttps://novasenta.com/

Last Round

Series B

Feb 5, 2024

Est. Valuation

$78M

Total Funding Raised

$75M

Company Overview

Novasenta is a biotechnology company that develops innovative immuno-oncology therapeutics and utilizes a machine-learning platform to discover potential drug targets within the tumor microenvironment, aiming to provide safer and more effective cancer treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoverycancer immunotherapybiotech startuptumor microenvironmentprecision medicinecomputational biologytarget identificationtherapeutic pipelinepreclinical researchdrug developmentai drug discoverybiotechpharma partneringin silico discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novasenta Comps

Public and private peers based on sector, stage, and business model.

Novasenta comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Novasenta Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Feb 5, 2024
Series A	Jul 29, 2022
Seed	Aug 23, 2021

View all Funding Rounds

Novasenta Investors

Notable investors and investment history

Novasenta investors
Investor	Rounds
UPMC	Series A
UPMC Enterprises	Seed, Series A

View all Investors

Novasenta Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Novasenta Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novasenta's valuation, stock price, and market status.

Firmographic Details

HeadquartersPittsburgh, Pennsylvania

Employee Range16

Year Founded2018

Last FundingFeb 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.